Holen Sie sich die Stockscreener-App
17.74
5.34%
0.90
Schlusskurs vom Vortag:
$16.84
Offen:
$16.98
24-Stunden-Volumen:
656.73K
Relative Volume:
0.60
Marktkapitalisierung:
$957.01M
Einnahmen:
$110.24M
Nettoeinkommen (Verlust:
$-66.44M
KGV:
-11.74
EPS:
-1.5111
Netto-Cashflow:
$-61.12M
1W Leistung:
+5.16%
1M Leistung:
-19.51%
6M Leistung:
+44.58%
1J Leistung:
-15.44%
1-Tages-Spanne:
$0.00
$0.00
1-Wochen-Bereich:
$16.32
$18.05
52-Wochen-Spanne:
$8.80
$32.71
Beta Bionics Inc Stock (BBNX) Company Profile
Firmenname
Beta Bionics Inc
Sektor
Branche
Telefon
949-427-7785
Adresse
11 HUGHES, IRVINE
Compare BBNX vs ABT, MDT, SYK, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BBNX
Beta Bionics Inc
|
17.74 | 957.01M | 110.24M | -66.44M | -61.12M | -1.5111 |
ABT
Abbott Laboratories
|
102.45 | 177.28B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
94.63 | 121.04B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
304.40 | 116.76B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
45.58 | 66.06B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
88.29 | 50.89B | 6.30B | 1.07B | 1.09B | 1.8406 |
Beta Bionics Inc Stock (BBNX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-10-12 | Eingeleitet | Jefferies | Buy |
| 2026-10-07 | Eingeleitet | Barclays | Overweight |
| 2026-09-23 | Eingeleitet | Wells Fargo | Overweight |
| 2026-08-21 | Eingeleitet | William Blair | Mkt Perform |
| 2026-07-28 | Fortgesetzt | UBS | Buy |
| 2026-02-09 | Eingeleitet | UBS | Buy |
| 2026-01-27 | Eingeleitet | TD Cowen | Hold |
| 2026-01-09 | Herabstufung | BofA Securities | Buy → Neutral |
| 2025-10-21 | Fortgesetzt | Stifel | Buy |
| 2025-10-01 | Hochstufung | Goldman | Neutral → Buy |
| 2025-06-16 | Eingeleitet | Truist | Buy |
| 2025-06-12 | Eingeleitet | Lake Street | Buy |
| 2025-05-30 | Eingeleitet | Goldman | Neutral |
| 2025-05-30 | Eingeleitet | Wolfe Research | Outperform |
| 2025-02-24 | Eingeleitet | BofA Securities | Buy |
| 2025-02-24 | Eingeleitet | Lake Street | Buy |
| 2025-02-24 | Eingeleitet | Leerink Partners | Outperform |
| 2025-02-24 | Eingeleitet | Piper Sandler | Overweight |
| 2025-02-24 | Eingeleitet | Stifel | Buy |
| 2025-02-20 | Eingeleitet | Ladenburg Thalmann | Neutral |
| 2025-02-20 | Eingeleitet | Robert W. Baird | Neutral |
Alle ansehen
Beta Bionics Inc Aktie (BBNX) Neueste Nachrichten
Bronstein, Gewirtz & Grossman LLC Urges Beta Bionics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm - GlobeNewswire Inc.
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Lincoln Educational Services Corporation Investors to Secure Counsel Before Important Deadline in Securities Class ActionLINC - GlobeNewswire Inc.
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Baidu, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class ActionBIDU - GlobeNewswire Inc.
BBNX DEADLINE: ROSEN, LEADING TRIAL COUNSEL, Encourages Beta Bionics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class ActionBBNX - GlobeNewswire Inc.
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Tigo Energy, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the FirmTYGO - GlobeNewswire Inc.
ROSEN, A LONGSTANDING FIRM, Encourages AppLovin Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – APP - GlobeNewswire Inc.
BBNX DEADLINE NOTICE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Beta Bionics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class ActionBBNX - GlobeNewswire Inc.
Beta Bionics, Inc. Class Action ReminderRobbins LLP Encourages BBNX Investors to Contact the Firm for Information About Their Rights - GlobeNewswire Inc.
Bronstein, Gewirtz & Grossman LLC Urges Beta Bionics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm - GlobeNewswire Inc.
Beta Bionics, Inc. Notice of November 3, 2026 Application - GlobeNewswire
Beta Bionics, Inc. Notice of November 3, 2026 Application Deadline for Class Action LawsuitContact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline - GlobeNewswire Inc.
AEVEX Corp. Notice of October 20, 2026 Application Deadline for Class Action LawsuitContact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline - GlobeNewswire Inc.
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Beta Bionics, Inc. of Class Action Lawsuit and Upcoming Deadlines – BBNX - GlobeNewswire Inc.
Kaplan Fox Encourages Investors of Beta Bionics, Inc. (NASDAQ: BBNX) to Contact the Firm Before the Securities Class Action Deadline on November 3, 2026 - The Globe and Mail
BETA BIONICS, INC. (BBNX) SHAREHOLDER ALERT Bernstein - GlobeNewswire
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Beta Bionics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class ActionBBNX - GlobeNewswire Inc.
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Beta Bionics, - GlobeNewswire
Markets & Stocks - FinancialContent
BBNX Investor Alert: Schall, Brown & Schwartz LLP Files - GlobeNewswire
symbol__ Stock Quote Price and Forecast - CNN
Chief commercial officer Hopman sells $7,015 of Beta Bionics stock By Investing.com - Investing.com Canada
ROSEN, A LEADING LAW FIRM, Encourages Beta Bionics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class ActionBBNX - GlobeNewswire Inc.
ROSEN, A LEADING LAW FIRM, Encourages Beta Bionics, Inc. - GlobeNewswire
Kaplan Fox Notifies Investors of Beta Bionics, Inc. (NASDAQ: BBNX) of the Lead Plaintiff Deadline on November 3, 2026 - The Globe and Mail
BBNX INVESTOR DEADLINE: Beta Bionics Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action LawsuitHBSS - GlobeNewswire Inc.
BBNX ALERT: Bragar Eagel & Squire, P.C. Announces that a - GlobeNewswire
FinancialContentKaplan Fox Reminds Investors of a Securities Class Action Against Beta Bionics, Inc. (NASDAQ: BBNX)Deadline is November 3, 2026 - FinancialContent
Beta Bionics, Inc. Notice of November 3, 2026 Application Deadline for Class Action LawsuitContact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline - GlobeNewswire Inc.
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Beta Bionics, - GlobeNewswire
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A - GlobeNewswire
Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against Unicycive Therapeutics, Inc. (UNCY), Hims & Hers Health, Inc. (HIMS), and Beta Bionics, Inc. (BBNX) Announced by Holzer & Holzer, LLC - GlobeNewswire Inc.
BBNX Stock Notice: Beta Bionics Stock Plummeted 37% after Medical Device Safety Issues DisclosedSecurities Fraud Class Action Filed - Lelezard
Deadline Alert: Beta Bionics, Inc. (BBNX) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit - GlobeNewswire Inc.
BBNX Investor Alert: Schall, Brown & Schwartz LLP Files Class Action Lawsuit Against Beta Bionics, Inc. and Announces Opportunity for Investors to Lead Class Action Lawsuit - Carroll County Mirror-Democrat
BBNX Investor Alert: Schall, Brown & Schwartz LLP Files Class Action Lawsuit Against Beta Bionics, Inc. and Announces Opportunity for Investors to Lead Class Action Lawsuit - mykxlg.com
BBNX Investor Alert: Schall, Brown & Schwartz LLP Files Class Action Lawsuit Against Beta Bionics, Inc. and Announces Opportunity for Investors to Lead Class Action Lawsuit - True North Radio Network
BBNX Investor Alert: Schall, Brown & Schwartz LLP Files - GlobeNewswire
BBNX Investors Have Opportunity to Lead Beta Bionics, Inc. Securities Fraud Lawsuit - Cortland Standard
BBNX Investors Have Opportunity to Lead Beta Bionics, Inc. Securities Fraud Lawsuit - YourGV.com
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Beta Bionics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class ActionBBNX - GlobeNewswire Inc.
Beta Bionics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Beta Bionics, Inc.BBNX - Morningstar
BBNX Investor Alert: Schall, Brown & Schwartz LLP Files Class Action Lawsuit Against Beta Bionics, Inc. and Announces Opportunity for Investors to Lead Class Action Lawsuit - Carroll County Mirror-Democrat
BBNX Investor Alert: Schall, Brown & Schwartz LLP Files - GlobeNewswire
Kaplan Fox Alerts GoDaddy Inc. (NYSE: GDDY) Investors to an Approaching Lead Plaintiff Deadline on October 20, 2026 - GlobeNewswire Inc.
Kaplan Fox Notifies Beta Bionics, Inc. (NASDAQ: BBNX) Investors of an Upcoming Lead Plaintiff Deadline on November 3, 2026 - GlobeNewswire Inc.
Kaplan Fox Reminds Beta Bionics, Inc. (NASDAQ: BBNX) Investors With Significant Losses to Seek a Leadership Role Before Deadline on November 3, 2026 - The Globe and Mail
Beta Bionics, Inc. (BBNX) stock price, news, quote and history - Yahoo Finance UK
רוזן, משרד מוביל בפריסה ארצית המייצג משקיעים, מעודד את משקיעי חברת Beta Bionics, Inc לשכור ייעוץ משפטי לקראת מועד אחרון חשוב במסגרת תביעה ייצוגית בניירות ערך – BBNX - GlobeNewswire Inc.
Beta Bionics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Beta Bionics, Inc.BBNX - GlobeNewswire Inc.
ROSEN, TOP-RANKED TRIAL ATTORNEYS, Encourages Doximity, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – DOCS - GlobeNewswire Inc.
Finanzdaten der Beta Bionics Inc-Aktie (BBNX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Beta Bionics Inc-Aktie (BBNX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Hopman Mark | Chief Commercial Officer |
Oct 01 '26 |
Sale |
18.96 |
370 |
7,015 |
56,109 |
| MARK HOPMAN | Officer |
Oct 01 '26 |
Proposed Sale |
18.98 |
2,660 |
50,487 |
0 |
| CHRISTINA JONES | Director |
Sep 22 '26 |
Proposed Sale |
22.04 |
8,942 |
197,082 |
0 |
| Jones Christy | Director |
Sep 22 '26 |
Sale |
23.00 |
6,430 |
147,890 |
19,564 |
| MARK HOPMAN | Officer |
Sep 16 '26 |
Proposed Sale |
19.23 |
28,119 |
540,728 |
0 |
| Mensinger Mike | Chief Product Officer |
Sep 16 '26 |
Sale |
22.00 |
2,650 |
58,300 |
177,390 |
| Hopman Mark | Chief Commercial Officer |
Sep 16 '26 |
Sale |
20.13 |
30,779 |
619,640 |
56,479 |
| MICHAEL MENSINGER | Officer |
Sep 16 '26 |
Proposed Sale |
19.23 |
5,300 |
101,919 |
0 |
| Hopman Mark | Chief Commercial Officer |
Sep 14 '26 |
Sale |
15.52 |
775 |
12,028 |
86,382 |
| Hopman Mark | Chief Commercial Officer |
Sep 09 '26 |
Sale |
18.46 |
36,870 |
680,723 |
87,157 |
3.41%
0.37%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):